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INTRODUCTION 
 
“MOVE FOR HEALTH” was the World Health Organization theme for the year 
2002. In most parts of the world, non-communicable diseases have become a major 
epidemic. This is due, in part, to a rapid change in lifestyles leading to reduced physical 
activity, changing diets and increased tobacco use. This trend is present in all societies, 
rich and poor, developed and developing.1 
The origin of the current epidemic of Cardiovascular Disease (CVD) can be 
traced back to the time of industrialization in the seventeen hundreds. The three factors 
responsible for this were an increase in the use of tobacco products, reduced physical 
activity and the adoption of a diet high in fat, calories and cholesterol. This rising tide of 
CVD continued into the 20th century.2 
Statistical projections show that 64 million people will die in 2015; 41 million 
(64%) of them will die from chronic diseases. This is a 17% increase in chronic disease 
deaths from 2005 to 2015. In 2005, chronic Non-Communicable Diseases (NCDs) 
accounted for 60% of all projected deaths worldwide – i.e. an estimated 35 million people 
died of NCDs. The projected 35 million deaths from chronic diseases is double the 
number of deaths from all infectious diseases (including Human Immunodeficiency Virus 
/ Acquired Immunodeficiency Syndrome, tuberculosis, and malaria), maternal and 
perinatal conditions, and nutritional deficiencies combined. Some 80% of the deaths from 
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NCDs occur in low and middle-income countries. The five major NCDs are heart disease, 
stroke, cancer, chronic respiratory diseases and diabetes.3  
Cardiovascular diseases (mainly heart disease and stroke) are responsible for 30% 
of all deaths. The Major Cardiovascular diseases include.4 
• Coronary (or ischaemic) heart disease (heart attack) 
• Cerebrovascular disease (stroke) 
• Hypertension (high blood pressure) 
• Heart failure 
• Rheumatic heart disease. 
The rise of cardiovascular diseases is attributed to a number of factors.  
The gradual reduction and elimination of infectious diseases affecting the young 
and middle-aged has led to longer lives. Longer life expectancy with increased 
proportions of older individuals in society has brought cardiovascular diseases to the 
forefront.  
Additionally, atherosclerotic diseases are associated with affluent lifestyles. 
Surplus food plus reduction in habitual physical activity results in obesity, which also 
encourages hyperlipidemia and hypertension.5 
The problem has serious impact. The burden of chronic disease:  
• has major adverse effects on the quality of life of affected individuals;  
• causes premature death;   
• and creates large adverse – and underappreciated – economic effects on families, 
communities and societies in general. 
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Chronic diseases undermine the macroeconomic development of many countries. 
Countries will forego billions in national income over the next 10 years as a result of 
premature deaths caused by heart disease, stroke, and diabetes. 
• China: $558 billion 
• Russian Federation: $303 billion 
• India: $237 billion.3  
 
The causes of the main chronic disease epidemics are well established and well 
known. The most important modifiable risk factors are:  
• unhealthy diet and excessive energy intake; 
• physical inactivity; 
• tobacco use. 
 
According to ‘The WHO STEP wise approach’6 a “risk factor” refers to any 
attribute, characteristic, or exposure of an individual, which increases the likelihood of 
developing a non-communicable disease. Surveillance of just eight selected risk factors 
(Table 1) which reflect a large part of future NCD burden can provide a measure of the 
success of interventions.  
The rationale for inclusion of core risk factors is therefore that: 
• they have the greatest impact on NCD mortality and morbidity; 
• modification is possible through effective primary prevention; 
• measurement of risk factors has been proven to be valid; and 
• measurements can be obtained using appropriate ethical standards.  
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Table 1 - Risk factors common to major non-communicable conditions.6 
 
Risk factor Condition 
 Cardiovascular  
disease*  
Diabetes Cancer Respiratory  
conditions** 
Smoking 
    
Alcohol 
 
 
 
 
Nutrition 
    
Physical inactivity  
   
 
Obesity 
    
Raised blood pressure  
  
  
Blood glucose  
   
 
Blood lipids  
   
 
* Including heart disease, stroke, hypertension. 
** Including chronic-obstructive pulmonary disease and asthma. 
Source(6) 
 
The major modifiable risk factors, in conjunction with the non-modifiable risk 
factors of age and heredity, explain the majority of new events of heart disease, stroke, 
chronic respiratory diseases and some important cancers. The major causes of chronic 
diseases are known, and if these risk factors were eliminated, at least 80% of all heart 
disease, stroke and type-2 diabetes would be prevented; over 40% of cancer would be 
prevented.3      
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OBJECTIVES 
 
1. To estimate the prevalence of selected modifiable cardiovascular risk factors 
among sales executives in an industrial population in Chennai. 
 
2. To study the distribution of risk factors across the various age groups. 
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JUSTIFICATION 
1. Cardiovascular Diseases are major contributors to the global burden of chronic 
diseases with 29.3% of global deaths and 9.9% of total disease burden, in terms of 
Disability Adjusted Life Years (DALYs) lost, being reported in 2003.7 Low and 
middle income countries accounted for 78% and 86%of CVD deaths and DALYs lost 
respectively, world wide in 1998.8 This burden of CVD is predicted to increase 
substantially in developing countries by the year 2020. 
2. In India CVD is projected to be the largest cause of death and disability by 20209 with 
2.6 million Indians predicted to die due to Coronary Heart Disease (CHD) which 
constitutes 54.1% of all CVD deaths.  
3. The burden of CVD is rising in India. In 2003, the prevalence of CHD in India was 
estimated to be 3-4 per cent in rural areas, and 8-10 per cent in urban areas, among 
adults older than 20 years, representing a two-fold rise in rural areas and a six-fold 
rise in urban areas over the past four decades, with a total of 29.8 million affected 
(14.1 million in urban areas, and 15.7 million in rural areas) according to population-
based cross-sectional surveys.10 
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4. Nearly half of these deaths are likely to occur among young and middle age 
individuals (30-69 years). This is because Indians experience CVD deaths at least a 
decade earlier than their counterparts in developed countries. This has the potential to 
adversely affect India’s economy with 52% of CVD deaths occurring in those below 
the age of 70 years compared to 23% in countries in established market economies.11 
5. The huge burden of CVD in Indian subcontinent is the consequence of the large 
population and high prevalence of cardiovascular risk factors.12 
6. These risk factors include smoking, alcohol, lower fruit and vegetable intake, physical 
inactivity, obesity, high blood pressure, raised blood glucose and abnormal blood lipids.6 
7. Recently, there were reports of high prevalence of these cardiovascular risk factors 
among industrial populations in various parts of India. Industrial units have captive 
population and therefore provide an opportunity to establish sentinel surveillance for 
cardiovascular risk factors.11,13 
8. As many of the industrial units in organized sector have their own primary health care 
facilities, it provides an opportunity for routine screening and follow-up. In addition, 
worksites are considered to be a key channel for the delivery of interventions to 
prevent cardiovascular disease.14 
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9. Job strain defined as the confluence of high job demands and low job control, has 
been associated with increased CVD prevalence.15 In Sweden, there are large 
differences in the incidence of myocardial infarction among occupational groups. 
Men aged <55yrs in high strain occupations showed an increase in the incidence of 
myocardial infarction compared to those in low strain occupations.16 The remarkably 
high proportion of American executives who felt they were under high and increasing 
stress is consistent with their cholesterol levels, which were much higher than would 
be expected from the results of the National Health Survey.17 It appeared that long 
working hours might increase systolic blood pressure in a field survey of 71 salesmen 
(22-60 years) in a machinery manufacturing company in Japan.18 
 
In view of the above reasons it was decided to conduct this study among a group of sales 
executives in an urban industrial population. 
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REVIEW OF LITERATURE 
 
HYPERTENSION 
Hypertension is the commonest cardio-vascular disorder, posing a major public 
health challenge to societies in socio-economic and epidemiological transition. It is one 
of the major risk factor for cardio-vascular mortality which accounts for 20-50% of all 
deaths .19 Hypertension is directly responsible for 57% of all stroke deaths and 24% of all 
coronary heart disease deaths in India.20  
 
Prevalence  
The prevalence of hypertension in India has been reported to range between 20–
40% in urban adults and 12–17% among rural adults.20 The number of people with 
hypertension is expected to increase from 118.2 million in 2000 to 213.5 million in 2025, 
with nearly equal numbers of men and women.21 
 
Blood Pressure Definition and Classification 
The arbitrary nature of the definition of hypertension has contributed to the 
variation in the definitions issued by various National and International authorities. 
Following the announcement of the Antihypertensive and Lipid-Lowering 
Treatment to Prevent Heart Attack Trial (ALLHAT)22 results at the end of 2002, the US 
hypertension guidelines were completely revised and reissued as the Seventh Report of 
the Joint National Committee on Prevention, Detection, Evaluation, and the Treatment of 
High Blood Pressure (JNC 7) in the Spring of 2003. 
 10 
Hypertension is currently defined as a usual Blood Pressure of 140/90 mm Hg or 
higher, Blood Pressure levels for which the benefits of pharmacological treatment have 
been definitely established in randomized placebo controlled trials.23 
Table 2- Classification of Blood Pressure for adults aged 18 years or older (JNC 7).23 
Classification of 
Blood Pressure 
Systolic Blood 
Pressure 
(mm of Hg) 
 Diastolic Blood 
Pressure 
(mm of Hg) 
Normal <120 And <80 
Prehypertension 120-139 Or 80-89 
Stage 1 hypertension 140-159 Or 90-99 
Stage 2 hypertension ≥160 Or ≥100 
 
Unlike the current US hypertension guidelines (JNC 7), the WHO/ International 
Society of Hypertension guidelines are aimed at a global audience and are intended to 
serve as a template for the development of national, regional, and local guidelines. In the 
WHO/ISH statement, there is no "prehypertension" classification. 
The World Health Organization (WHO)/ International Society of Hypertension 
(ISH) blood pressure classification includes 3 grades of hypertension (Table 2a).24 
Table 2a - WHO/ISH Classification of Hypertension24 
HYPERTENSION Systolic Blood Pressure 
(mm of Hg) 
Diastolic Blood Pressure 
(mm of Hg) 
Grade 1 140-159 90-99 
Grade 2 160-179 100-109 
Grade 3 ≥180 ≥110 
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Accurate measurements of blood pressure are essential under standardized conditions 
for valid comparison between persons or groups over time. Three sources of errors have 
been identified in the recording of blood pressure. 
1. Observer errors 
2. Instrumental errors 
3. Subject errors. 
 
Etiology 
Hypertension is divided into primary (essential) and secondary hypertension. In 
over 90% of patients with hypertension no specific cause can be identified. These patients 
are diagnosed as having primary hypertension or essential hypertension. 
The small minority of patient in whom specific cause can be identified are diagnosed 
as having secondary hypertension. Prominent among these are 
• Diseases of kidney 
• Tumours of adrenal glands 
• Congenital narrowing of the aorta 
• Toxemia of pregnancy. 
 
Cardiovascular Disease Risk 
  Subjects with hypertension are known to have a higher risk of two-fold 
developing coronary artery disease, four times higher risk of congestive heart failure 
and seven times higher risk of cerebrovascular disease and stroke compared to 
normotensive subjects.25 Even the high normal blood pressure (Systolic Blood Pressure 
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130 to 139 mm Hg, Diastolic Blood Pressure 85 to 89 mm Hg or both) augments risk of 
CVD twofold as compared with lower levels.26 
As the population ages, the prevalence of hypertension will increase even further 
unless broad and effective preventive measures are implemented.23 The relationship 
between Blood Pressure and risk of cardiovascular disease events is continuous, 
consistent, and independent of other risk factors. The higher the Blood Pressure, the 
greater the chance of myocardial infarction, heart failure, stroke and kidney disease. For 
individuals aged 40 to 70 years, each increment of 20 mm Hg in Systolic Blood Pressure 
(SBP) or 10 mm Hg in Diastolic Blood Pressure (DBP) increases the risk of CVD across 
the entire Blood Pressure range from 115/75 to 185/115 mm Hg.27 The classification of 
prehypertension in JNC 7, recognizes this relationship and signals the need for increased 
education of health care professionals and the public to decrease Blood Pressure levels 
and prevent the development of hypertension in the general population.28  
 
Hypertension prevention strategies are available to achieve this goal. 
Lifestyle Modifications 
Adoption of healthy lifestyles by all individuals is critical for the prevention of 
high Blood Pressure and an indispensable part of the management of those with 
hypertension. Major lifestyle modifications shown to lower Blood Pressure include 
weight reduction in those individuals who are overweight or obese; adoption of Dietary 
Approaches to Stop Hypertension eating plan, which is rich in potassium and calcium; 
dietary sodium reduction; physical activity; and moderation of alcohol consumption 
(Table 3). 
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Source (23) 
Pharmacologic Treatment 
Excellent clinical trial outcome data prove that lowering Blood Pressure with 
several classes of drugs, including angiotensin converting enzyme inhibitors, angiotensin-
receptor blockers, beta-blockers, calcium channel blockers, and thiazide-type diuretics, 
will all reduce the complications of hypertension.  
 
Prevention and control of hypertension 
The WHO recommended the following approaches for the prevention of hypertension. 
1. Population approach which reduces the risk of developing high blood pressure in 
the population as a whole. 
2. Individual approach which identifies the individuals with high blood pressure who 
are at increased risk of developing complications.  
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The combination of individual and population approach provides a comprehensive 
strategy for prevention and control of hypertension. 
In population approach, the prevention of elevated Blood Pressure is principally 
linked to the elimination of modifiable risk factors that contribute to its rise and 
promotion of protective factors that help maintain blood pressure in the desirable range 
associated with low risk of complications.  
This approach helps the individual to adopt a healthier lifestyle by keeping a normal 
body weight, eating less salt, consuming less alcohol, increasing physical activity and 
changes in behaviour such as cessation of tobacco smoking and improved diet. 
Encouraging change in behaviour in communities and individuals requires a collaborative 
effort between health professionals, policy makers, industry, media and other opinion 
formers as well as sustained campaign that targets all sections of the community and all 
ages.  
The concept of the population approach is based on the fact that even a small 
reduction has the potential to produce not only a substantial reduction in the prevalence 
of hypertension, but a surprisingly large decrease in cardiovascular risk. The goal of 
the population approach is to shift the community distribution of blood pressure towards 
lower level or biological normality. 
The individual approach focuses on the people at high risk. Family history of 
hypertension, tracking of blood pressure from childhood may be used to identify the 
individual at risk. 
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DIABETES MELLITUS 
Definition  
Diabetes mellitus is a group of metabolic diseases characterized by hyperglycemia 
resulting from defects in insulin secretion, insulin action, or both.29 
The risk of CHD is 2-3 times higher in diabetics than non diabetics. CHD is 
responsible for 30 to 50 per cent of deaths in diabetics over 40 years in industrialized 
countries.30 
Prevalence  
The Indian subcontinent has a higher prevalence of diabetes mellitus than any 
other region in the world, and 2-3 times the reported prevalence in Western countries.31 
The prevalence of type-2 diabetes in urban Indian adults has been reported to have 
increased from less than 3% in 1970 to about 12% in 2000. The Indian Council of 
Medical Research (ICMR) estimates that the prevalence of diabetes is 3.8 per cent in 
rural areas, compared with 11.8 per cent in urban areas.32 
Classification  
Clinical classification of diabetes mellitus30 
1. Diabetes mellitus  
i. Insulin-dependent diabetes mellitus (IDDM, Type 1) 
ii. Non-insulin dependent diabetes mellitus (NIDDM, Type 2) 
iii. Malnutrition-related diabetes mellitus (MRDM) 
iv. Other types (secondary to pancreatic hormonal, drug-induced, 
genetic and other abnormalities) 
2. Impaired glucose tolerance (IGT) 
3. Gestational diabetes mellitus (GDM) 
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Criteria for the diagnosis of diabetes mellitus29 
1. Symptoms of diabetes plus casual plasma glucose concentration ≥200 mg/dl 
(11.1mmol/l). Casual is defined as any time of day without regard to time since 
last meal. The classic symptoms of diabetes include polyuria, polydipsia, and 
unexplained weight loss. 
or 
2. Fasting Plasma Glucose ≥126 mg/dl (7.0mmol/l). Fasting is defined as no caloric 
intake for at least 8hours. 
or 
3. 2-h postload glucose ≥200 mg/dl (11.1mmol/l) during an Oral Glucose Tolerance 
Test (OGTT). The test should be performed as described by WHO, using a 
glucose load containing the equivalent of 75 g anhydrous glucose dissolved in 
water. 
In the absence of unequivocal hyperglycemia, these criteria should be confirmed by 
repeat testing on a different day. The third measure (OGTT) is not recommended for 
routine clinical use. 
 
Diabetes and CVD risk. 
In men with diabetes, hypercholesterolemia, smoking, and hypertension predict 
coronary mortality risk, as well as mortality risk from all causes.33 Even in the 
absence of the above risk factors diabetes alone results in increased relative risk of 
cardiovascular mortality.34 
Diabetes is also strongly associated with classical risk factors- elevated levels of 
triglycerides and low-density lipoprotein cholesterol, with decreased levels of high-
density lipoprotein cholesterol. There is also high prevalence of obesity and 
hypertension among diabetics.35 
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Prevention of Diabetes 
Two strategies for primary prevention have been suggested. 
• Population strategy 
• High-risk strategy 
Population strategy 
The scope for primary prevention of NIDDM is limited on the basis of current 
knowledge and is not appropriate. However, the development of prevention programmes 
for NIDDM based on elimination of environmental risk factors is possible. There is 
pressing need for primordial prevention (prevention of emergence of risk factors in 
countries in which they have not yet appeared). The preventive measures comprise 
maintenance of normal body weight through adoption of healthy nutritional habits 
(adequate protein intake, a high intake of dietary fibre and avoidance of sweet foods) and 
physical exercise. These measures should be fully integrated into other community-based 
programmes for non-communicable diseases. 
High-risk strategy 
There is no special high-risk strategy for IDDM diabetes. At present, there is no 
practical justification for genetic counselling as a method of prevention. 
Since NIDDM appears to be linked with sedentary lifestyle, over-nutrition and obesity, 
correction of these may reduce the risk of diabetes and its complication. Alcohol should 
be avoided. Those at risk should avoid diabetogenic drugs such as oral contraceptive 
pills. It is wise to reduce factors that promote atherosclerosis, e.g. smoking, high Blood 
Pressure, elevated cholesterol and high triglyceride levels. These programmes may most 
effectively be directed at target population groups.  
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DYSLIPIDEMIA 
Definition 
Dyslipidemia refers to the derangements of one or many of the lipoproteins; 
elevations of total cholesterol, Low-Density Lipoprotein (LDL) cholesterol and/or 
triglycerides, or low levels of High-Density Lipoprotein (HDL) cholesterol, while 
elevation of lipoproteins alone is labeled as ‘hyperlipidemia’.36 
Prevalence  
The prevalence of hypercholesterolemia was 28% in urban subjects as compared 
to 22% in the rural subjects in a study among adult males in Rajasthan.37 The ICMR 
surveillance project reported a prevalence of dyslipidemia (defined as a ratio of total to 
HDL cholesterol >4.5) of 37.5% among adults aged 15-64 yr, with an even higher 
prevalence of dyslipidemia (62%) among young male industrial workers.38 
Classification of Total Cholesterol 
Cholesterol is a fat-like substance, found in the blood stream and also in bodily 
organs and nerve fibers. Most cholesterol in the body is made by the liver from a wide 
variety of foods, but especially from saturated fats, such as those found in animal 
products. 
Total cholesterol is the most widely used blood measure.39 
Table 4 - Adult Treatment Panel III (ATP III) Classification of Total Cholesterol40 
 
Total Cholesterol level 
 
Classification 
<200 mg/dl (5.2 mmol/L) 
 
Desirable  
200-239 mg/dl (5.2-6.2 mmol/L) 
 
Borderline high  
>240 mg/dl (6.2 mmol/L) 
 
High  
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Total cholesterol is commonly divided into three major components based on the 
density of the particles:  low-density lipoprotein (LDL) cholesterol, high-density 
lipoprotein (HDL) cholesterol, and Very Low-Density Lipoprotein cholesterol. Each of 
these fractions is associated with specific protein carrier molecules. 
Low-density lipoprotein is the largest component of total cholesterol and is the 
atherogenic fraction. High-density lipoprotein is a smaller fraction and is inversely 
related to coronary heart disease. The very low density lipoprotein contains modest 
amounts of cholesterol, but is the main carrier for triglycerides. Triglycerides are the 
major entity by which fat is transported and stored in the body. 
 
Etiology 
A primary dyslipidemia (e.g. familial hypercholesterolemia) typically refers to a 
genetic defect in the lipid metabolism that causes abnormal lipid levels.  
A secondary dyslipidemia may be due to a variety of reasons;  
• environmental factors (diet rich in saturated fat or a sedentary lifestyle),  
• diseases (type 2 diabetes, hypothyroidism, etc.), and  
• medications (thiazide diuretics, progestins, anabolic steroids etc.).  
Secondary dyslipidemias could be corrected or ameliorated by treating the underlying 
disorder. 
Hypercholesterolemia and CVD 
Globally, a substantial proportion of cardiovascular disease-one third of ischemic 
stroke and over half of Ischaemic Heart Disease is attributable to non-optimal cholesterol 
(defined as mean cholesterol >3.8 mmol/l). 
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• Data from prospective cohort studies have demonstrated a strong, continuous 
temporal association between cholesterol and Ischaemic Heart Disease 
• The associations between age and cholesterol for males increased between the 
ages of 30 and 50 years, and then flattened before declining slightly in older age. 
• The relative risk of Ischaemic Heart Disease increased with increasing cholesterol 
level, and the association was roughly linear when plotted on a log scale.  
• Cholesterol is positively associated with ischemic stroke.41 
 
A combination of hypertriglyceridemia, low levels of HDL-cholesterol and high levels of 
small dense low-density lipoprotein, termed as “atherogenic dyslipidemia’, is particularly 
seen in Asian Indians.  
A multitude of factors may contribute to dyslipidemia in Asian Indians.36 
• Physical Activity: Asian Indians are more physically inactive as compared to 
many ethnic groups.  
• Diet: Asian Indian diets rich in carbohydrate and low in ω-3 polyunsaturated fatty 
acids may exacerbate hypertriglyceridemia. 
• Body Composition: Migrant Asian Indians and Asian Indians residing in urban 
India have body composition conducive to development of dyslipidemia.  
• Genetic predisposition 
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OBESITY 
Definition 
Obesity may be defined as an abnormal growth of the adipose tissue due to an 
enlargement of fat cell size (hypertrophic obesity) or an increase in fat cell number 
(hyperplastic obesity) or a combination of both.42 
Measurement and classification  
Height and weight are the most simple and commonly used measures. A number 
of weight-for-height indices have been developed of which the Body Mass Index (BMI) 
is the most widely used. It is defined as the weight in kilograms divided by the square of 
the height in metres (kg/ m2). Although it can sometimes misclassify total body fat 
content, BMI generally correlates highly with adiposity. Therefore BMI, which is easy to 
calculate, has been recommended as the measure of obesity for adults to be used in all 
studies.43 
Table 5 - Classification of adults according to BMI (WHO Classification) 
Classification BMI (kg/m2) Risk of co-morbidities 
Underweight <18.5 Low (but increased risk of 
other clinical problems) 
Normal range 18.5 – 24.9 Average 
Overweight ≥ 25  
     Preobese 25 – 29.9 Increased 
     Obese I 30 – 34.9 Moderate 
     Obese II 35 – 39.9 Severe 
     Obese III ≥ 40 Very Severe 
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It is not just the amount of fat but also its distribution that determines the risk 
associated with obesity. Abdominal or visceral fat (android obesity) is associated with the 
cardiovascular risk factors of the Metabolic Syndrome. These include Type 2 diabetes, 
impaired glucose tolerance, and hypertension and dyslipidaemia (high triglyceride, low 
LDL cholesterol). It is the mass of visceral adipose tissue which leads to these 
abnormalities. 
Obesity and CVD risk  
Increased mortality among the obese is evident for several life-threatening 
diseases including Type 2 diabetes, cardiovascular disease (relative risk 2-3, moderately 
increased risk), gallbladder disease, and certain types of cancers. Risks are also higher for 
some non-fatal conditions such as back pain, arthritis, infertility and, in many 
westernized countries, poor psychosocial functioning.  
Long-term prospective data suggest that obesity may be an independent risk 
factor for CHD. The degree of obesity is related to the rate of development of CHD and 
even moderate overweight appears to increase risks of CHD. Weight loss accompanies 
improvements in blood pressure and cholesterol.  
A proposal has been made to redefine the classification of obesity using BMI for 
Asian population (Table 6) as there are now evidence that the increased risks of co-
morbidities with obesity occurs at a lower BMI in Asians.44 
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Table 6 - Classification of weight by BMI in adult Asians 
Classification BMI (kg/ m2) Risk of co-morbidities 
Underweight <18.5 Low (but increased risk of 
other clinical problems) 
Normal range 18.5 – 22.9 Average 
Overweight ≥23  
     At risk 23 – 27.4 Increased Risk 
     Obese  ≥27.5 High Risk 
 
Prevalence  
Many cross-sectional surveys, as well as the industrial surveillance project, 
recorded a high urban prevalence of central obesity and overweight (especially when the 
lower thresholds recommended by WHO for Asian people are used). Though the 
prevalence of obesity (BMI ≥ 30 kg/ m2) is usually lower than that observed in the 
western population, the overweight category (BMI ≥ 25 kg/ m2) includes almost a third to 
half the population in every survey.45,46   
Prevention and control 
 
Weight control is widely defined as approaches to maintaining body weight 
within the ‘healthy’ range of BMI of 18.5 to 24.9 kg/ m2 throughout adulthood. It should 
also include prevention of weight gain of more than 5 kg in all people. In those who are 
already overweight, a reduction of 5-10 percent of body weight is recommended as an 
initial goal. The control of obesity centers around weight reduction. This can be achieved 
by dietary changes, increased physical activity as well as a reduction in smoking and 
alcohol consumption. 
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PHYSICAL ACTIVITY 
Physical activity is defined as any body movement that results in the expenditure 
of energy. It includes sports and activities such as walking, cycling, playing, skating, 
cleaning the house, dancing or climbing the stairs. It is thus part of daily life. 
There is international consensus on the value of regular moderate physical 
activity. This can be provided by at least 30 minutes of physical activity daily. The total 
of 30 minutes does not have to be performed in a single session; it can be accumulated 
throughout the day.47 
Prevalence 
As a result of economic changes and increased mechanization, the prevalence of 
physical inactivity is increasing in India, particularly in urban areas, to levels comparable 
with the West.48 In the INTERHEART study, the prevalence of leisure time physical 
activity was substantially lower among South Asians (6.1%) compared with the rest of 
the world (21.6%).49  
Physical activity and CVD risk 
Regular physical activity reduces the risk of obesity, blood lipid abnormalities, 
hypertension, and non-insulin dependent diabetes mellitus50, and has been shown to 
reduce substantially the risk of CHD. Conversely, measures of sedentary lifestyles or 
physical inactivity have been associated with a 1.5 to 2.4 fold elevation in CHD risk51 A 
recent hospital-based case control study from two urban centers in India suggested that 
daily moderate intensity physical activity (e.g., the equivalent of briskly walking 35- 40 
min per day) is associated with a 55 per cent lower risk for CHD52. 
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Benefits to health of physical activity47 
Physical activity has the following benefits: 
• a 50% reduction in the risk of developing coronary heart disease, adult diabetes or 
obesity; 
• a 30% reduction in the risk of developing hypertension; 
• a decline in blood pressure in hypertensive people; 
• maintenance of bone mass and thus protection against osteoporosis; 
• improved coordination, mobility, strength and endurance; and 
• raised self-esteem, reduced levels of mild to moderate hypertension and overall 
psychological wellbeing. 
 
 
SMOKING 
Prevalence 
  In 2002, a national survey of tobacco use reported that the Indian subcontinent, 
second only to China in both the production and consumption of tobacco products, had an 
alarming rate of current tobacco use of 56 per cent among Indian men aged 12-60 yr.53 
Data from the Global Youth Tobacco Survey shows that the Proportion currently using 
any tobacco product among 13 to 15 years old is 17.3 % (males) and 9.7% (females) and 
the Proportion currently smoking cigarettes 5.9 % (males) and 1.8% (females). 
 
Smoking and Cardiovascular risk 
Cigarette smokers have higher death rates from coronary heart disease than 
nonsmokers. This relationship is stronger for men than women. Cigarette smoking 
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markedly increases an individual’s susceptibility to earlier death from coronary heart 
disease. Cigarette smoking, hypertension and elevated serum cholesterol are major risk 
factors contributing to the development of coronary heart disease. Cigarette smoking acts 
both independently and conjointly with these other factors to increase the risk of 
developing coronary heart disease. Cigarette smoking may contribute both to the 
development of coronary heart disease and to the exacerbation of pre-existing coronary 
heart disease; both nicotine and carbon monoxide are thought to contribute to these 
abnormal processes. Cigarette smoking is associated with a significant increase in 
atherosclerosis of the aorta and coronary arteries. Cessation of smoking is associated with 
a decreased risk of death from coronary heart disease.54 The degree of developing 
coronary heart disease is directly related to the number of cigarettes smoked per day55 
New data reaffirm the already well documented causal association of smoking with the 
risk for CHD. Compared with lifetime nonsmokers, the relative risk in smokers rises with 
the number of cigarettes smoked and falls after cessation. The type of cigarette smoked 
has little influence on CHD risk. Products with lower yields of tar and nicotine, as 
measured by a smoking machine, have not been found to reduce CHD risk substantially 
and they are not a lower-risk alternative for smokers who cannot quit.56 
Little data have existed regarding the association between the use of other forms 
of tobacco and the risk of CVD; however, a recent analysis of data from the 
INTERHEART case-control study of risk factors for acute myocardial infarction has 
documented that there is an increased risk of myocardial infarction associated with all 
forms of smoked and smokeless tobacco.57 
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Prevention Strategy 
The tobacco epidemic is preventable. In May 2003, the WHO World Health 
Assembly unanimously adopted the WHO Framework Convention on Tobacco 
Control (FCTC), one of the United Nations’ most widely embraced treaties – and the 
world’s first against tobacco – in order to galvanize action at the global and country level 
against the tobacco epidemic. 
To expand the fight against the tobacco epidemic, WHO has introduced the 
MPOWER58 package of six proven policies:  
• Monitor tobacco use and prevention policies,  
• Protect people from tobacco smoke,  
• Offer help to quit tobacco use, 
• Warn about the dangers of tobacco, 
• Enforce bans on tobacco advertising, promotion and sponsorship, and 
• Raise taxes on tobacco. 
The MPOWER58 policy package can reverse the tobacco epidemic and prevent millions 
of tobacco-related deaths. 
Legal provisions for Tobacco control in India and Tamil Nadu 
Cigarettes and Other tobacco products (Prohibition of Advertisement and 
Regulation of Trade and Commerce, Production, Supply and Distribution) Act, 2003. 
Four Key Areas : 
• Prohibition of smoking in a public place – section 4 
• Prohibition of advertisement of cigarettes and other tobacco products – section 5 
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• Prohibition on sale of cigarettes or other tobacco products to and by minors and in 
a particular area – section 6 
• Specified health warning labels on all tobacco products including pictorial 
warnings– sections 7,8,9,10. 
The Tamil Nadu Prohibition of Smoking And Spitting Rules 2003. 
ALCOHOL 
High alcohol intake defined as 75 g or more per day is an independent risk factor 
for CHD, hypertension and all cardiovascular diseases.59 
Evidence that regular light-to-moderate drinking has a beneficial effect on the 
cardiovascular system comes from physiological and individual-level epidemiological 
studies. How-ever, aggregate-level, time-series analyses have failed to confirm this 
effect.  
Binge drinkers (i.e., women who consumed five or more drinks on an occasion, or 
men who consumed nine or more drinks on an occasion) had higher risks for major 
coronary events than abstainers, even when over-all volume of drinking was low.  
Specifically, heavy drinking occasions have been shown to increase low density 
lipoproteins, which have been linked to negative cardiovascular outcomes.  
In addition, irregular heavy drinking is associated with increased risk for the 
formation of blood clots within blood vessels (i.e., thrombosis), which occurs at the end 
of a heavy drinking occasion. 
Finally, irregular heavy drinkers seem predisposed to structural (i.e., histological) 
changes in the heart muscle and the adjacent impulse-conducting system, which regulate 
the threshold for ventricular fibrillation.60 
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In the face of good evidence that shows a relationship between consumption of 
alcoholic beverages and various types of cardiovascular harm, in addition to the 
considerable doubt about the benefits with respect to ischaemic heart disease, alcohol 
should be treated as a risk factor in the aetiology of cardiovascular diseases.61 
 
SALES EXECUTIVE  
 A person employed to represent a business and to sell its merchandise.62 
Job description of a sales executive63 
Sales executives maximise the sales of a company's goods or services in many 
different settings. Their role helps to ensure the commercial success of a diverse range of 
companies. 
 
Sales executives are responsible for increasing and developing sales in areas including: 
• fast moving consumer goods (such as food and stationery);  
• consumer durables (clothes, domestic equipment and toys);  
• industrial supplies;  
• IT, software and media;  
• services (such as print and financial services). 
The requirement to meet and exceed targets means that the role is demanding and 
involves working under frequent pressure. Travel within a working day, absence from 
home at night and overseas work or travel, are all common. The constant travel, 
sometimes with overnight stays or longer business trips, can affect social/home life.  
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The work environment has most often been used to study chronic stress as it leads to 
coronary artery disease.64 The most commonly used demand/control model hypothesis 
predicts that the most adverse reactions of psychological strain occur when the 
psychological demands are high and the worker's decision latitude is low: job strain. 
According to Robert Karasek, two scales, decision latitude and psychological demands 
are used to measure the high demand/low control model of job strain development.65 
When the two job characteristic scales-decision latitude and psychological demands-are 
arrayed as a four-quadrant diagram, we get: 
• Active job quadrant (upper right) with high demand and high control, has high-
prestige occupations: public officials, physicians, engineers, nurses, and managers 
of all kinds.         
• Passive job quadrant (lower left), with low demands and low control, has clerical 
workers such as billing clerks, and low-status service personnel such as janitors. 
• High-strain quadrant (lower right), with high demands and low control, has 
machine-paced operatives such as assemblers, cutting operatives, freight handlers, 
salespersons as well as other low-status service operatives such as waiters. 
• Low-strain self-paced occupations (upper left) often involve significant training 
and self-pacing, such as repairmen, linemen, and natural scientists. 
Organized sector 
Manufacturing sector plays a vital role in Indian economy. It contributes almost 25% 
of GDP in the Indian economy. Manufacturing sector is further subdivided into 2 parts-
organized sector and unorganized sector. Organized sector means the units registered 
under Section 2m of Factories Act, 1948 and unorganized sector means the rest.66 
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Definition of Industry 
 
As per Section 2(j) of Industrial Disputes Act, 1947 “Industry” means any 
systematic activity carried on by co-operation between an employer and his workmen 
(whether such workmen are employed by such employer directly or by or through any 
agency, including a contractor) for the production, supply or distribution of goods or 
services with a view to satisfy human wants or wishes (not being wants or wishes which 
are merely spiritual or religious in nature). 
A new initiative for a healthy nation 
National Programme for Prevention and Control of Diabetes, Cardiovascular 
Diseases and Stroke (NPDCS)67  
Pilot phase of the National Programme for Prevention and Control of Diabetes, 
Cardiovascular Diseases and Stroke (NPDCS) was launched on 4th Jan 2008 by Deputy 
Chairman, Planning Commission in the august presence of Honorable Minister for Health 
&Family Welfare and Honorable Minister of State. 
States and Districts covered for Pilot Phase  
One district in each of the following states covered for pilot Phase 
Table 7 - States and Districts selected for the pilot phase 
State District 
Assam Kamrup 
Punjab Jalandhar                                              
Rajasthan Bhilwara 
Karnataka Shimoga 
Tamilnadu Kancheepuram 
Kerala Thiruvanathapuram 
Andhra Pradesh Nellore(tentative) 
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 Objectives of the pilot phase 
1. To assess the prevalence of risk factors for Non- Communicable Diseases  
2. Risk reduction for prevention of NCDs (Diabetes, CVD and Stroke)  
3. Early diagnosis and appropriate management of Diabetes, Cardiovascular 
Diseases and Stroke  
Strategies 
a. Surveillance of risk factors of Non-Communicable Diseases. 
b. Health Promotion for the General Population. 
c. Disease Prevention for the High Risk groups.  
a. Assessment of prevalence of NCD risk factors  
To study the distribution of risk factors for Non-Communicable Diseases especially 
Diabetes, CVD and Stroke-through repeated surveys in the population will include 
1. Demographic and socio-economic characteristics 
2. Tobacco/Alcohol use 
3. Physical activity 
4. Dietary patterns 
5. BMI and waist circumference measurements 
6. Blood pressure 
7. Blood glucose and Lipids 
b. Health Promotion 
1. Enabling environments 
Through an effective communication & community mobilization in 
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i. Schools  
ii. Communities (rural and urban) 
iii. Workplaces 
2. Implementation through  
Non Governmental Organizations, School Health Committees, Ward 
Committees,  Accredited social health activists ASHAs, Self Help Groups 
and Employees Unions  
Key issues to be addressed  
1. Healthy food habits  
2. Control of Overweight and Obesity 
3. Regular physical activity  
4. Avoidance of tobacco and  
5. Stress management 
6. Control of Blood Pressure, Blood Sugar and Blood Cholesterol/Lipids. 
 
c. Disease prevention for the High Risk 
 will be achieved through 
i. Reorienting the Public Health Delivery system. 
ii. Setting up of special clinics. 
iii. Harnessing the Private Sector. 
iv. Specific interventions at tertiary level. 
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Expected outcomes for the pilot phase 
• Population distribution of NCD risk factors made available 
• Awareness generated on HEALTHY LIFE STYLES  
• Health promotion at School , Community & Work places 
• Health system capacity building for prevention and control of NCDs 
• Methodology and approaches finalized for Nationwide implementation. 
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METHODOLOGY 
 
BACK GROUND INFORMATION 
The study was conducted in the corporate office of a Fast Moving Consumer 
Goods Company in South Chennai. The office was selected based on the feasibility of 
long term follow up of the cohort with limited resources. An in-house functional medical 
center with a physician, medical aide and a records section was also present. There were 
nearly 1000 employees working in the office in various capacities. A total of 676 persons 
were employed as sales executives. In this particular organization, the sales employees 
were required to visit the depots and retail stores and check for supply and availability of 
stock, in the areas of their jurisdiction which covered various areas in the city of Chennai. 
This required travel approximately 50-70 kilometers per day, irregular diet habits (eating 
outside and improper timings) and irregular working hours.   
STUDY DESIGN   
This study was done as a cross-sectional descriptive study of all sales executives 
in the 20–59 years age group. 
STUDY PERIOD 
The study was conducted during the period between July 2008 to September 2008. 
 
STUDY POPULATION  
A list of all potential participants was obtained from the human resources 
department. A total of 676 persons were employed as sales executives. All of them were 
invited to participate in the study. Of the 676 individuals, 608 (89.94% of total, 5 women 
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and 603 men) agreed to participate in the study. Here the results of the men are reported, 
as the number of women who participated in the study was small 5 (0.82%). 
 
SAMPLE SIZE 
All the eligible employees were included in the study; however for estimation of 
the sample size, the following calculation was used. 
Formula 
n = Z∝2 pq 
                      d2 
where Z∝2 = 1.96 for 95% confidence interval. 
Here the sample size was arrived at with the prevalence of major CVD risk factor 
hypertension 27.2% as reported in a study conducted among an urban industrial 
population in South India.68  
n = number of samples to be studied 
p = 27.2% 
q = 72.8% 
d = 15% of p  
   = 15% of 27.2 = 4.08 
Substituting values in the formula 
 n = Z∝2 pq 
                                  d2 
We get, 
n = 1.96×1.96×27.2×72.8 = 456.97 
               4.08×4.08 
 
Sample size = 457 
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SELECTION CRITERIA 
Inclusion criteria: Adults who are willing to participate in the study. 
Exclusion criteria: Those who were not willing participate in the study. 
 
DATA COLLECTION 
Approval for conducting the study was obtained from the management. 
Participation in the study was voluntary and all the measurements were carried out in the 
medical unit located within the industry under the supervision of the in house physician. 
Informed oral consent was obtained from each participant after explaining about the 
nature of the study. Data on socio-demographic aspects, tobacco consumption, alcohol 
consumption, physical activity, anthropometric measurements, blood pressure 
measurements and blood samples for biochemical measurements were collected from all 
the study subjects. All the study subjects were individually counselled on methods to 
reduce risk factors. Newly detected patients with hypertension, diabetes, and 
hypercholesterolemia were referred to the in house physician for further management. At 
the end of the study, a copy of the report of the study was submitted to the management.  
 
STUDY METHOD 
The three components of the study were.  
(1) Questionnaire based survey for behavioural risk factors,  
(2) Anthropometric measurements  
(3) Blood Pressure and Biochemical measurements. 
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Questionnaire for demographic and behavioural risk factors  
A simple semi-structured questionnaire consisting of objective type questions was 
developed and modified by pilot testing and on expert advice. 
The questionnaire was used to collect data on demographic and behavioural risk 
factors. The first part sought information on the socio-demographic aspects like age, sex, 
occupation, education, monthly income and marital status. 
The second part sought self reported information on lifestyle-related factors such as 
physical activity, smoking and alcohol consumption; and any history related to previous 
diagnosis and treatment for hypertension and diabetes. 
Questions on tobacco included data on self reported frequency and quantity of tobacco 
consumption. Individuals were classified as non-smoker or smoker (only one person 
consumed smokeless tobacco and all the others smoked cigarettes). 
Self reported alcohol intake data was collected and subjects were classified as consumer 
and not a consumer.  
Anthropometric measurements 
Weight was measured in the upright position with the help of an adult portable-
weighing machine (bathroom scale). The same machine was used throughout the study. 
The scale was adjusted to zero reading before weighing. Accuracy of the scale was 
checked every week with standard weight. Weighing was done with minimum dressing 
and without shoes. 
Height was measured without shoes using calibrated stadiometer.  
Body mass index (BMI) was calculated using the Quetelet’s index. 
B.M.I.  = Weight in kg  
                Height in m2 
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Measurement of Blood Pressure 
Blood pressure was measured from the right arm after the subject had been sitting quietly 
with the back supported for at least five minutes and arm supported at the level of the 
heart. 
1. No caffeine during the hour preceding the reading. 
2. No smoking during the fifteen minutes preceding the reading. 
3. No exertion of any kind preceding the measurements.69 
  The gold standard for routine blood pressure measurement is a Standard mercury 
column sphygmomanometer with cuff size 13cms x 35cms. The bladder should encircle 
and cover 2/3rd of the length of the arm. The lower edge of the cuff should be about 
2.5cms above the anterior cubital fossa. The manometer should be placed on a horizontal 
surface at the level of the heart.  
The blood pressure was recorded with the same sphygmomanometer and by the 
same observer. ‘0’ reading was ensured before recording the blood pressure each time. 
The cuff pressure was inflated to 30mmHg above the level at which the radial pulse 
disappeared, then deflated slowly at the rate of 2mm/second and the reading recorded to 
the nearest 2mm. The first and the fifth Korotkoff sounds were taken as indicative of the 
systolic and diastolic blood pressure respectively. 
Two readings were made at five minutes interval as per the WHO 
recommendation. 
When high blood pressure greater than or equal to 140/90mmHg was noted a third 
reading was made after thirty minutes. Lowest of the three was recorded. 
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Biochemical measurements 
 
Five ml of blood was collected from ante-cubital vein in two test tubes. Blood 
sample for plasma glucose was collected in the test tube containing heparin sodium 
fluoride. Plasma glucose and total cholesterol were measured using an auto-analyzer. The 
GOD – POD (glucose oxidase – peroxidase) method and CHOD – PAP (cholesterol 
oxidase / p – aminophenazone) method were used for measuring plasma glucose and 
serum cholesterol respectively at an accredited laboratory. Re-analysis of 10% of samples 
selected randomly was done at the Institute of Biochemistry, Madras Medical College as 
a quality assurance measure.  
Statistical analysis 
 Data was entered in EXCEL-2003 and analyzed using Epi-info2002 version-6 
computer package (developed by Center for Disease Control and Prevention (CDC), 
U.S.A. and WHO, Geneva). ANOVA test was used between mean values of CVD risk 
factors and age groups. Continuous data are summarized as means and standard 
deviations and categorical data as proportions. Chi-square test was used for categorical 
variables and P-value < 0.05 was considered statistically significant. Odds ratios were 
calculated between other risk factors and hypertension. 
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DEFINITIONS 
Smoking 
Current smoker: Smoked at least one cigarette during the last 30 days.70 
 
Alcohol 
Current drinkers: those who consumed at least one alcoholic beverage in the past 30 
days. A drink was defined as a 355ml beer, 148ml wine, and 37ml liquor.71 
Current regular use: Alcohol intake for more than three times (average) a week. 
Current occasional use: Alcohol intake for more than three times a month, but less than 
three times a week.11 
BMI classification: Subjects were classified using WHO classification43 and 
classification recently recommended for Asians.44 
Hypertension: Defined as systolic blood pressure (SBP) of ≥140 mmHg or diastolic 
blood  pressure (DBP) ≥90 mmHg as per WHO criteria24 or history of previously known 
disease and pre-hypertension was defined as SBP 120-139 mmHg or DBP 80-89 
mmHg.23 
Type 2 Diabetes mellitus: Diagnosed either by history of previously known disease or 
fasting plasma glucose of ≥126 mg/dl and impaired glucose tolerance was defined as 
plasma glucose 101 – 125 mg/dl.29  
Hypercholesterolemia: Defined as total cholesterol level ≥ 200 mg% according to USA 
- adult treatment panel (ATP) III guidelines.40 
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RESULTS AND DISCUSSION 
 
ORGANIZATION OF DATA 
 
SECTION – A:  DEMOGRAPHIC CHARACTERISTICS 
 
SECTION – B:  PHYSIOLOGIC BASELINE DATA 
 
SECTION – C:  PREVALENCE OF RISK FACTORS 
 
SECTION – D:  EFFECT OF AGE ON CVD RISK FACTORS 
 
SECTION – E:  EFFECT OF ADIPOSITY ON CVD RISK FACTORS 
 
SECTION – F:  ASSOCIATION BETWEEN HYPERTENSION AND  
                           OTHER RISK FACTORS 
 
 
 
 
 
 
 
 43 
SECTION – A. DEMOGRAPHIC CHARACTERISTICS 
The study was conducted in a corporate office in south Chennai. Of the 676 sales 
executives, 608 individuals (89.94% of total, 5 women and 603 men) agreed to 
participate in the study. Here the results of the men are reported, as the number of women 
who were eligible and participated in the study was small 5 (0.82%).  
The study population included 603 males aged 22-59 years. The blood samples 
were collected for all subjects. Mean age was 37.68 ±9.19years. Nearly one third 
209(34.7%) of the participants were in the 40–49 years’ age group. All had graduate or 
post-graduate level education. All were semi-professionals belonging to the upper middle 
class, average family income was Rs.11,500 per month (8000-15000). Among the study 
subjects 537(89.1%) were married and 66(10.9%) were unmarried, 107(17.7%) were 
vegetarians and 496(82.3%) were mixed-diet consumers. 
 
 
FIGURE-1: AGE DISTRIBUTION 
26%
29% 
35%
10%
20-29years
30-39years
40-49years
50-59years
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SECTION – B. PHYSIOLOGIC BASELINE DATA 
The mean values of various clinical, laboratory and anthropometric measurements 
are given in Table 8. 
Table – 8: Mean And Standard Deviation For Various Cardiovascular Disease Risk 
Factors In The Study Population 
S.No. Variables Mean 
Standard 
Deviation 
Range 
1. Age(years) 37.68 9.19 22-59 
2. Height(cm) 172.03 6.32 149-188 
3. Weight(kg) 75.81 11.05 45-121 
4. Body Mass Index(kg/m2) 25.61 3.42 15.55-37.74 
5. Systolic Blood Pressure(mmHg) 130.25 14.62 100-200 
6. Diastolic Blood Pressure(mmHg) 84.15 9.27 60-130 
7. Fasting Blood Sugar(mg/dl) 100.96 41.69 70-351 
8. Total Serum Cholesterol(mg/dl) 203.00 38.34 54-368 
 
Anthropometric measurements 
The results showed a mean BMI of 25.61 kg/m2 which is higher than the Normal range 
(18.5 – 24.9 kg/m2). It is in the Pre-obese range (25 – 29.9 kg/m2). 
Clinical and biochemical measurements 
Blood pressure 
Mean systolic blood pressure (SBP) was 130.25mmHg and mean diastolic blood pressure 
(DBP) was 84.15mmHg. 
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The normal SBP is <120mmHg and DBP is <80mmHg. So the mean Blood Pressure 
values for the study population are higher than normal they are in the pre-hypertensive 
range. 
Biochemical measurements 
Mean Fasting Blood Sugar was 100.96mg/dl. 
The mean Fasting Blood Sugar value for the study population is higher than normal. It is 
in the pre-diabetic range (100-125mg/dl). 
Mean Total Serum Cholesterol was 203.00mg/dl 
The mean Total Serum Cholesterol value for the study population is higher than 
desirable. It is in the Borderline high range (200-239 mg/dl) 
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SECTION – C. PREVALENCE OF RISK FACTORS 
 
BEHAVIOURAL RISK FACTORS 
Community-based cross-sectional surveys and other studies carried out in the past 
few decades have revealed a high and increasing prevalence of CVD and its risk factors 
in Indians residing, in India72,73,74,75 as well as in other countries.76,77 
 
SMOKING 
The number of study subjects who were smokers (ever smoked) was 181(30.0%, 
95% Confidence Interval 26.4% to 33.9%), current smokers were 149 (24.7%) and ex-
smokers 32(5.3%) as seen in (Fig-2).  
FIGURE-2 SMOKING PATTERN
70.0%
5.3%
24.7%
Nil Ex-Smokers Current Smokers
 
Similar results were found in other studies conducted in industrial settings. Kaur 
et al., 78 reported a prevalence of 33.3% smoking in their study, Mehan et al. ,79 reported 
that smoking was prevalent in 31.4% study subjects in their profile of NCD risk factors in 
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an industry in Gujarat and Gupta et al.,80 reported a prevalence 36.5% among the urban 
population of Jaipur. 
 
ALCOHOL CONSUMPTION 
Alcohol consumption was prevalent in 279(46.3%, 95% Confidence Interval 
42.2% to 50.3%) subjects (ever consumed). Of the study subjects 3.3% were past 
consumers and 43.0% were present consumers (Fig-3). 
FIGURE-3:ALCOHOL CONSUMPTION
53.7%
43.0%
3.3%
Nil Past Consumer Present Consumer
 
Kaur et al., reported a prevalence of 34.8% in their study done to determine the 
prevalence of cardiovascular risk factors in two industrial units in Chennai, India. Studies 
in northern India found the 1 year prevalence of alcohol use to be between 25 and 40%.81 
In southern India, the prevalence of current alcohol use varies between 33 and 50%, with 
a higher prevalence among the lesser educated and the poor.82 Mohan et al., 83 (2001) 
conducted a survey in three districts (central, north and north-east India), they reported a 
prevalence of current alcohol use of 20–38% in males and of 10% among females. 
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PHYSICAL ACTIVITY 
Apart from daily activities 331(54%, 95% Confidence Interval 50.8% to 58.9%) 
of the participants took part in some kind of physical activity. The various types of 
physical activities performed are shown in Fig.-4. 
Physical inactivity was prevalent among 272 (45.1%, 95% Confidence Interval 41.1% to 
49.2%) of the study subjects. 
 
FIGURE-4: PHYSICAL ACTIVITY
45.1%
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Yoga 
 
Gupta R. et al,84 reported the prevalence of physical inactivity (defined as-walk 
less than 14.5km per week, climbs less than 20 flights of stairs per week, or no moderate 
physical activity (300kcal/day) on 5 days per week) 85% (81% in males and 92% in 
females). Kaur et al., reported that based on the physical activity levels, 243(10.7%) in 
their industrial population were sedentary and 675 (29.8%) had heavy physical activity 
levels. 
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ANTHROPOMETRIC MEASUREMENTS 
 
BODY MASS INDEX 
 
Prevalence of overweight (BMI 25.0 kg/m2-29.9 kg/m2) and obesity (BMI ≥ 30.0 
kg/m2) using WHO definition was 44.9%and 10.1% respectively. The overall prevalence 
of over weight (BMI >25 kg/m2) was 55.1%, 95% Confidence Interval 51.0% to 59.1%.  
Table – 9: Frequency And Percentage Distribution Of Body Mass Index (WHO 
Definition) 
S.No. Classification BMI (kg/m2) Frequency Percent 
1. Underweight <18.5 15 2.5%  
2 Normal range 18.5 – 24.9 256 42.5%  
3. Pre-obese 25 – 29.9 271 44.9%  
4. Obese  30 – 40 61 10.1%  
 
As per WHO recommendations for defining risk thresholds among Asians, 52.9% were in 
increased risk (BMI 23.0 kg/ m2-27.4 kg/m2) and 26.5% were in high-risk (BMI ≥ 27.5 
kg/m2) category,  the prevalence of overweight based on the WHO recommendations for 
Asians (BMI >23 kg/m2) was 79.4%.(Table10) 
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Table – 10: Frequency And Percentage Distribution Of Body Mass Index  
(WHO Recommendation for Asians) 
S.No. Classification BMI (kg/m2) Frequency Percent 
1. Underweight <18.5 15 2.5%  
2 Normal range 18.5 – 22.9 109 18.1%  
3. Pre-obese 23 – 27.4 319 52.9% 
4. Obese  27.5 – 40 160 26.5% 
 
Mean BMI and prevalence of overweight and high-risk BMI in this population 
was higher as compared to other industrial settings. This could be due to better socio-
economic status and more urbanized study population.  
 
CLINICAL AND BIOCHEMICAL MEASUREMENTS 
 
HYPERTENSION 
Based on history of previously known disease, only 9.1% were aware of their 
blood pressure status. (Table-11) 
Table – 11: Past History Of Hypertension 
S.No. History of Hypertension Frequency Percent 
1. Not a Known Hypertensive 548 90.9%  
2 Known Hypertensive on 
Treatment  
55 9.1%  
3. Total  603 100.0%  
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Table – 12: Frequency And Percentage Distribution Of Hypertension 
S.No Hypertension Frequency Percent 
1. Normal 54 8.9%  
2. Pre-hypertension  247 41.0%  
3. Self Reported 55 9.1% 
4. Newly Detected 247 41.0% 
5. Total  603 100.0%  
 
In this study pre-hypertension was present in 247(41.0%) and hypertension was 
prevalent in 302 (50.1%, 95% Confidence Interval, 46.0% to 54.1%) subjects 
respectively. Among the hypertensives, 247 (81.78%) were newly detected (Table-12).  
Table – 13: Classification Of Blood Pressure Levels (Combined)  n=603 
(mm of Hg) Frequency 
S.No Category SBP DBP Newly 
detected 
Known 
hypertensive 
Total 
(Percent)  
1 Normal B.P. 
 
<120 <80 54 0 54(9.0%) 
2 Pre-hypertension 
120-139 80-89 247 8 255(42.3%) 
3 Grade 1 hypertension 
140-159 90-99 195 25 225(36.5%) 
4 Grade 2 hypertension 
160-179 100-109 48 18 66(10.9%) 
5 Grade 3 hypertension 
≥180 ≥110 4 4 8(1.3%) 
 
Among the hypertensives in the study population, 36.5%were grade 1 or mild 
degree hypertension, 10.9% were grade 2 or moderate degree of hypertension and 1.3% 
were grade 3 or severe hypertension. Among known hypertensives only 8(14.54%) had 
blood pressure under control (SBP <140 mmHg and DBP<90 mmHg).  
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Chokalingam A et al.,85 found that pre-hypertension was prevalent in 47.4% of 
adults, and another 34.7% had hypertension in a cross-sectional survey among 2,007 
adults in Chennai in July 2003. Prabhakaran et al.,86  reported a prevalence of pre-
hypertension of 40% and hypertension 20% among men in a large industry of northern 
India. Kaur et al., reported findings of pre-hypertension 39.8% and hypertension 27.2% 
in an industrial population in south India. 
The prevalence of hypertension among the subjects in this study was higher than 
that observed in other studies. This could be due to the unique work profile of the study 
population. Hazarika et al.,87 in their study on Hypertension and its risk factors in tea 
garden workers of Assam also found a higher prevalence of hypertension (60.8%).  
Consistent with other industrial studies, awareness and control of hypertension 
was low. Hypertension remains undetected and uncontrolled even in organized sector 
industries with medical facilities. 
 
DIABETES 
Based on history of previously known disease, self reported prevalence of 
diabetes was 9.6%.  
Table – 14: Past History Of Diabetes 
S.No. History of Diabetes Frequency Percent 
1. Not a Known Diabetic 545 90.4%  
2 Known Diabetic on Treatment  58 9.6%  
3. Total  603 100.0%  
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Impaired fasting glucose was prevalent in 85(14.1%) and Diabetes Mellitus was 
prevalent in 86(14.3%, 95% Confidence Interval 11.6% to 17.4%) subjects respectively. 
Among the diabetics, 28(32.6%) were newly detected. Among known diabetics, 29 
(50.0%) had blood glucose under control (<126 mg/dl). 
Table – 15: Frequency And Percentage Distribution Of Diabetes 
S.No. Diabetes Frequency Percent 
1. Normal 432 71.6% 
2. Impaired Fasting Glucose 85 14.1% 
3. Self Reported 58 9.6% 
4. Newly Detected 28 4.7% 
5. Total 603 100.0%  
 
The prevalence of diabetes in this study was consistent with the recent Indian 
studies. Prabhakaran et al., observed that the prevalence of impaired fasting 
glucose30.7% and Diabetes Mellitus was 15%. Kaur et al.,78 observed that the prevalence 
of impaired fasting glucose 16.1% and Diabetes Mellitus was 16.3%. In the multi-centric 
study done in industrial settings in India the prevalence of Diabetes Mellitus was found to 
be 10.1% and Gupta et al., reported a prevalence of 13.1% Diabetes Mellitus among men. 
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HYPERCHOLESTEROLEMIA 
Hypercholesterolemia (total cholesterol ≥200 mg/dl) was observed in 308(51.1%, 
95% Confidence Interval 47.0% to 55.1%) subjects. 
Table – 16: Frequency And Percentage Distribution Of Hypercholesterolemia 
S.No. Serum Cholesterol Frequency Percent 
1. Normal(<200mg/dl) 295 48.9% 
2. Hypercholesterolemia(≥200mg/dl) 308 51.1% 
3. Total 603 100.0% 
 
Kaur et al., found the prevalence of Hypercholesterolemia to be 30.3% in their 
study done to determine the prevalence of cardiovascular risk factors in two industrial 
units in Chennai, India, Prabhakaran et al., observed that the prevalence of 
Hypercholesterolemia was 30.1%, Gupta et al.,80 reported a prevalence of 28.5% among 
the urban population of Jaipur. 
The high prevalence of Hypercholesterolemia in this study population may be due 
to better socio-economic status and their dietary habits. 
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SECTION – D. EFFECT OF AGE ON CVD RISK FACTORS 
Table – 17: Age Distribution of CVD Risk Factors    n = 603 
20-29 
years 
n=156 
30-39 
years 
n=176 
40-49 
years 
n=209 
50-59 
years 
n=62 Cardio-vascular disease risk factor No. % No. % No. % No. % 
Chi-
square 
Hypertension YES 
NO 
47 
109 
30.1 
69.9 
90 
86 
51.1 
48.9 
119 
90 
56.9 
43.1 
46 
16 
74.2 
25.8 
χ2=43.27 
P=0.0000 
Diabetes YES 
NO 
5 
151 
3.2 
96.8 
16 
160 
9.1 
90.9 
42 
167 
20.1 
79.9 
23 
39 
37.1 
62.9 
χ2=51.70 
P=0.0000 
Hyper- 
cholesterolemia 
YES 
NO 
61 
95 
39.1 
60.9 
93 
83 
52.8 
47.2 
124 
85 
59.3 
40.7 
30 
32 
48.4 
51.6 
χ2=15.05 
P=0.0018 
BMI≥25kg/m2 YES 
NO 
59 
97 
37.8 
62.2 
99 
77 
56.3 
43.7 
130 
79 
62.2 
37.8 
44 
18 
71.0 
29.0 
χ2=29.49 
P=0.0000 
Smoking YES 
NO 
52 
104 
33.3 
66.7 
54 
122 
30.7 
69.3 
63 
146 
30.1 
69.9 
12 
50 
19.4 
80.6 
χ2=4.21 
P=0.2396 
Alcohol 
consumption 
YES 
NO 
76 
80 
48.7 
51.3 
91 
85 
51.7 
48.3 
87 
122 
41.6 
58.4 
25 
37 
40.3 
59.7 
χ2=5.16 
P=0.1603 
Physically 
Active 
YES 
NO 
68 
88 
43.6 
56.4 
90 
86 
51.1 
48.9 
131 
78 
62.7 
37.3 
42 
20 
67.7 
32.3 
χ2=18.30 
P=0.0004 
 
The prevalence of Hypertension (By history of previously known disease or SBP 
≥140 or DBP ≥ 90mmHg) steadily increased with age, in the age group of 20-29 years, it 
 56 
was 30.1% which increased rapidly and reached a prevalence of 74.2% in the age group 
of 50-59 years. 
The prevalence of Diabetes (By history of previously known disease or fasting 
plasma glucose of ≥126 mg/dl) steadily increased with age, in the age group of 20-29 
years, it was 3.2%. There was sharp increase in prevalence of Diabetes above the age of 
39 years and rapidly reached a prevalence of 37.1% in the age group of 50-59 years.  
The prevalence of Hypercholesterolemia (Total cholesterol level ≥ 200 mg/dl) 
steadily increased with age, in the age group of 20-29 years, it was 39.1%. The 
prevalence of Hypercholesterolemia increased up to 49 years and plateaued thereafter to 
reach a prevalence of 48.4% the age group of 50-59 years. 
The prevalence of Overweight (BMI≥25kg/m2) individuals steadily increased 
with age, in the age group of 20-29 years, it was 37.8% which increased rapidly and 
reached a prevalence of 71.0% in the age group of 50-59 years.  
The prevalence of Smoking was roughly similar in all the age groups, with a 
decline in the prevalence in the age group of 50-59 years. 
The prevalence of Alcohol consumption was roughly similar in all the age groups, 
with a small peak in the prevalence 57.1% in the age group of 30-39 years. 
The prevalence of Physical Activity significantly increased with age, in the age 
group of 20-29 years, it was 43.6% and reached a prevalence of 67.7% in the age group 
of 50-59 years (probably due to better awareness and advice from company physician). 
Prabhakaran et al., observed that diabetes, hypertension, overweight, showed 
rising trends with age, while the prevalence of smoking, was roughly similar in all the 
age groups. Even the youngest age group of 20–29 years had a high prevalence of risk 
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factors such as dyslipidaemia, hypertension and diabetes. The prevalence of hypertension 
and pre-hypertension increased with age in the multi-centric study.11 Kaur et al.,78 in their 
study found that there was significant increase in prevalence of current smoking, high 
risk BMI, central obesity, hypertension, diabetes, hypercholesterolemia with increasing 
age (p<0.001). 
In this study as age increased there was a significant increase in the prevalence of 
diabetes, hypertension, high risk BMI and hypercholesterolemia as seen in Fig-5. 
Table – 18: Mean Values Of CVD Risk Factors By Age    n = 603 
Cardio-vascular disease 
risk factor 
20-29 
years 
n=156 
 
30-39 
years 
n=176 
40-49 
years 
n=209 
50-59 
years 
n=62 
F – statistic 
p - value 
Systolic Blood 
Pressure(mmHg) 
Mean 
 
SD 
124.42 
12.51 
128.07 
12.36 
133.49 
15.22 
140.16 
15.73 
F = 25.21  
p = 0.0000 
Diastolic Blood 
Pressure(mmHg) 
Mean 
 
SD 
80.51 
8.41 
84.08 
8.95 
85.90 
9.31 
87.58 
9.35 
F = 14.20 
p = 0.0000 
Fasting Blood 
Sugar(mg/dl) 
Mean 
 
SD 
89.88 
32.68 
96.61 
32.36 
109.30 
50.18 
113.10 
45.84 
F = 9.21 
p = 0.0000 
Total Serum 
Cholesterol(mg/dl) 
Mean 
 
SD 
194.97 
34.54 
203.84 
39.99 
207.70 
37.65 
204.98 
42.54 
F = 3.45 
p = 0.0164 
Body Mass 
Index(kg/m2) 
Mean 
 
SD 
24.17 
3.36 
25.82 
3.22 
26.08 
3.37 
27.01 
3.18 
F = 15.26 
p = 0.0000 
 
 In this study there was a significant increase in the mean values of CVD risk 
factors as age increased. Similar finding were reported by Kutty VR et al,88 in a study 
conducted in a population in South Kerala. 
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SECTION – E. EFFECT OF ADIPOSITY ON CVD RISK FACTORS 
 
Table–19: Distribution of CVD Risk Factors According To Body Mass Index(kg/m2) 
          n = 603 
Under- 
weight  
<18.5 
n=15 
Normal 
range 
18.5–24.9 
n=256 
Pre- 
obese 
25 – 29.9 
n=271 
Obese 
30 – 40 
n=61 
Cardio-vascular 
disease risk factor 
No. % No. % No. % No. % 
Chi-
square 
Hypertension 
YES 
NO 
1 
14 
6.7 
93.3 
107 
149 
41.8 
58.2 
150 
121 
55.4 
44.6 
44 
17 
72.1 
27.9 
χ2=33.21 
p=0.0000 
Diabetes 
YES 
NO 
0 
15 
0 
100 
35 
221 
13.7 
86.3 
40 
231 
14.8 
85.2 
11 
50 
18 
82 
χ2=3.33 
p=0.3432 
Hyper- 
cholesterolemia 
YES 
NO 
5 
10 
33.3 
66.7 
124 
132 
48.4 
51.6 
144 
127 
53.1 
46.9 
35 
26 
57.4 
42.6 
χ2= 4.03 
p=0.2580 
 
 
There was a continuous graded increase in the prevalence of hypertension with 
increasing BMI and this was highly significant (Chi-Square for linear trend 30.99 
p=0.0000).There was an increase in the prevalence of diabetes and hypercholesterolemia 
with increasing BMI but this was not statistically significant (see Table-19 & Fig-6).  
Prabhakaran et al., reported that there was a continuous graded increase in mean 
values as well as risk factor prevalence with increasing BMI. Ramachandran et al.,89 in a 
study from Chennai observed increasing trend of diabetes at lower BMI. Deshmukh et 
al.,90 observed hypertension in rural Indian population at lower BMI. 
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Table – 20: Mean Values Of CVD Risk Factors By BMI (kg/m2) n =603 
 
Cardio-vascular disease 
risk factor 
Under- 
weight  
<18.5 
n=15 
Normal 
range 
18.5–
24.9 
n=256 
Pre- 
obese 
25 – 
29.9 
n=271 
Obese 
30 – 40 
n=61 
F – statistic 
p - value 
Systolic Blood 
Pressure(mmHg) 
Mean 
 
SD 
116.67 
9.76 
127.88 
14.01 
131.57 
13.62 
137.71 
17.83 
F = 13.36 
p = 0.0000 
Diastolic Blood 
Pressure(mmHg) 
Mean 
 
SD 
76.00 
7.37 
82.34 
8.59 
85.03 
8.80 
89.84 
11.03 
F = 16.77 
p = 0.0000 
Fasting Blood 
Sugar(mg/dl) 
Mean 
 
SD 
83.80 
10.49 
99.91 
43.26 
104.11 
44.58 
95.56 
19.30 
F = 1.77 
p = 0.1513 
Total Serum 
Cholesterol(mg/dl) 
Mean 
 
SD 
186.67 
36.58 
200.63 
36.74 
204.89 
40.33 
208.59 
35.29 
F = 1.89 
p = 0.1285 
 
Among the study subjects, the mean values of SBP and DBP increased 
significantly as the BMI increased. In the third examination cycle of the Framingham 
Offspring Study, BMI was significantly and linearly associated with systolic blood 
pressure, fasting glucose levels, plasma total cholesterol in a study conducted by Lamon-
Fava et al.,.91  
When the BMI is divided into smaller categories with class intervals of 
1kilogram/m2 also the linear trend is obvious, as seen in Fig-7.   
 62 
                             
FI
GU
R
E-
 
7:
 
Pr
o
po
rti
o
n
 
o
f s
tu
dy
 
su
bje
ct
s 
w
ith
 
hy
pe
rte
n
si
o
n
, 
di
ab
et
es
 
an
d 
hy
pe
rc
ho
le
st
er
o
le
m
ia
 
ac
ro
ss
 
bo
dy
 
m
as
s 
in
de
x
 
ra
n
ge
.
(n=
60
3)
01020304050607080
</=
21
.
0
21
.
1-2
2.0
22
.
1-2
3.0
23
.
1-2
4.0
24
.
1-2
5.0
25
.
1-2
6.0
26
.
1-2
7.0
27
.
1-2
8.0
28
.
1-2
9.0
>2
9.0
B
o
dy
 
m
as
s 
in
de
x
 
(kg
/m
2)
Percentage of subjects (%)
HY
PE
R
TE
NS
IO
N
DI
AB
ET
ES
HY
PE
RC
HO
LE
ST
ER
O
LE
MI
A
 63 
Effect Of Smoking And Alcohol Consumption On Selected CVD Risk Factors  
There was no significant difference in the prevalence of CVD risk factors among smokers 
and non-smokers and among alcohol consumers and non-consumers.(Table 21 & 22) 
Table – 21: Distribution of CVD Risk Factors According To Smoking Status 
Smokers 
n=181 
Non-Smokers 
n=422 Cardio-vascular 
disease risk factor No. % No. % Chi-square 
Hypertension YES 
NO 
85 
96 
47.0 
53.0 
217 
205 
51.4 
48.6 
χ2=1.01 
p=0.3154 
Diabetes YES 
NO 
28 
153 
15.5 
84.5 
58 
364 
13.7 
86.3 
χ2=0.31 
p=0.5786 
Hyper-
cholesterolemia 
YES 
NO 
97 
84 
53.6 
46.4 
211 
211 
50 
50 
χ2=0.65 
p=0.4188 
 
Table – 22: Distribution of CVD Risk Factors According To Alcohol Consumption  
Alcohol 
Consumers 
n=279 
Non-Consumers 
n=324 Cardio-vascular disease risk factor No. % No. % 
Chi-square 
Hypertension YES 
NO 
144 
135 
51.6 
48.4 
158 
166 
48.8 
51.2 
χ2=0.49 
p=0.4856 
Diabetes YES 
NO 
36 
243 
12.9 
87.1 
50 
274 
15.4 
84.6 
χ2=0.78 
p=0.3759 
Hyper-
cholesterolemia 
YES 
NO 
153 
126 
54.8 
45.2  
155 
169 
47.8 
52.2 
χ2=2.94 
p=0.0865 
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SECTION – F. ASSOCIATION BETWEEN HYPERTENSION AND OTHER 
RISK FACTORS 
 
Table – 23: Distribution Of CVD Risk Factors According To Hypertension Status 
Hypertension 
Cardio-vascular 
disease risk factor YES NO 
Chi-square 
BMI≥25kg/m2 YES 
NO 
194 
108 
138 
163 
χ2 = 20.61 
p = 0.0000 
Diabetes YES 
NO 
52 
250 
34 
267 
χ2 = 4.33 
p = 0.0376 
Hyper-
cholesterolemia 
YES 
NO 
156 
146 
152 
149 
χ2 = 0.08 
p = 0.7812 
Smoking YES 
NO 
85 
217 
96 
205 
χ2 = 1.01 
p = 0.3154 
Alcohol 
Consumption 
YES 
NO 
144 
158 
135 
166 
χ2 =0.49 
p = 0.4856 
Physical 
Activity 
YES 
NO 
175 
127 
156 
145 
χ2 =2.28 
p = 0.1310 
 
Significant relationship of hypertension was observed with high risk BMI (OR: 
2.12; 95% CI=1.53 - 2.94; P=0.0000), and Diabetes (OR: 1.63; 95% C.I.=1.03 - 2.60; 
P=0.0192). No significant relationship could be observed for hypercholesterolemia, 
smoking, alcohol consumption and physical activity. 
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SUMMARY 
 
The results of this study indicated a high prevalence of behavioral risk factors 
(smoking and alcohol consumption), obesity, hypertension, diabetes and 
hypercholesterolemia among middle and high-income young males in an urban industrial 
population in Chennai. Prevalence of these risk factors increased during the most 
productive years putting them at risk of cardiovascular morbidity and mortality at 
relatively younger age. This population provided an opportunity to study the influence of 
socioeconomic and lifestyle transition on the prevalence of cardiovascular risk factors. 
The results were consistent with the multi-centric study done in industrial settings in 
India. 
Study population included 603 males aged 22-59 years. The blood samples were 
collected for all subjects. Mean age was 37.68 ±9.19years. Nearly one third 209(34.7%) 
of the participants were in the 40–49 years’ age group. All had graduate or post-graduate 
level education. All were semi-professionals belonging to the upper middle class. 
Average family income was Rs.11,500 per month (8000-15000). 
Tobacco consumption was prevalent in 181(30.0%) subjects and 279(46.3%) of 
the study subjects were alcohol consumers. 
Prevalence of overweight (BMI 25.0 kg/m2-29.9 kg/m2) and obesity (BMI ≥ 30.0 
kg/m2) using WHO definition was 44.9%and 10.1% respectively. As per WHO 
recommendations for defining risk thresholds among Asians, 52.9% were in increased 
risk (BMI 23.0 kg/m2-27.4 kg/m2) and 26.5% were in high-risk (BMI ≥ 27.5 kg/m2) 
category. 
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Pre-hypertension and hypertension were prevalent in 247(41.0%) and 302 
(50.1%) subjects respectively. Among the hypertensives, 247 (81.78%) were newly 
detected. Among known hypertensives, 8(14.54%) had blood pressure under control 
(SBP <140 mmHg and DBP<90 mmHg). 
Prevalence of impaired fasting glucose and diabetes mellitus was 85(14.1%) and 
86(14.3%) respectively. Among the diabetics, 28(32.6%) were newly detected. Among 
known diabetics, 29 (50.0%) had blood glucose under control (<126 mg/dL). 
308(51.1%) of the subjects had raised total cholesterol. 
There was significant increase in prevalence of high risk BMI, hypertension, 
diabetes, hypercholesterolemia with increasing age. 
Prevalence of hypertension, diabetes and hypercholesterolemia increased across 
the BMI range. The linear trend was statistically significant for hypertension. 
Significant relationship of hypertension was observed with BMI (OR: 2.12; 95% 
CI=1.53 - 2.94; P=0.0000) and Diabetes (OR: 1.63; 95% CI=1.03 - 2.60; P=0.0192). 
No significant relationship could be observed for other risk factors. 
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RECOMMENDATIONS 
 
Most of us understand that the health or ill-health of workers in an industry is 
related to the hazards posed by the occupational environment. The effects of Lifestyle 
diseases are likely to be similar to those outside the working environment. In a way, the 
industrial worker is ‘captive’ whose major lifestyle gets adapted to his/her work needs.92 
The rationale of screening these workers for NCD risk factors is not justified unless these 
activities are strongly linked to continuous and holistic health promotion programs. These 
issues have been laid down in the technical and ethical guidelines of the International 
Labour Organization for industrial workers.93 
Also, in the absence of a population based nationally representative surveillance 
system for CVD, establishing a multi-centric surveillance system in industrial settings 
could be a useful initial step. 
The high prevalence of risk factors is a cause for concern, organized sector 
industries provide a unique opportunity for carrying out prevention programmes. It is 
estimated that there are nearly 6 million people working in such large organized sector 
industries in India. While most of these have their own primary healthcare facilities, they 
also provide for the healthcare of employees and their dependents in higher medical 
institutions when required. With the rising burden of CVD, the expenditure on such 
healthcare programmes by every industry is likely to increase enormously. Thus, there is 
a lot of scope for and benefit in initiating comprehensive, low-cost CVD prevention 
programmes at the workplace for employees and their dependants. Such onsite 
programmes have been found to be modestly successful in the West through increased 
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awareness, health education and risk reduction interventions, and modified models could 
easily be adapted to Indian settings. This is likely to lead to a healthier workforce as well 
as a decrease in expenditure by the industry on treatment costs and increased 
absenteeism.  
The importance of workplace health promotion was addressed in 1950 and later 
updated in 1995 in a joint International Labour Organization/World Health Organization 
session on occupational health. 
In response to the global burden imposed by non-communicable diseases, WHO 
developed the Global Strategy on Diet, Physical Activity and Health94 (DPAS), which 
was adopted by the 57th World Health Assembly in May 2004. The World Health 
Organization /World Economic Forum Joint Event was held in Dalian, People’s Republic 
of China, on 5-6 September 2007. The report summarizes the current evidence available 
in addressing the different dimensions of the workplace as a key setting for interventions 
designed to prevent NCD through diet and physical activity. 
The workplace as a health promotion setting 
• this setting can serve to improve the health status of workers and contribute to a 
positive and caring image of the company.  
• improvements in staff morale and productivity, and reductions in staff turnover, 
absenteeism and sick leave.  
• reductions in health plan costs, workers' compensation and disability costs.  
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• significant proportion of time spent at work by the large majority of the population  
• it offers an opportunity to utilize peer pressure to encourage employees to make 
desirable alterations to their health habits. 
Senior managers may have a variety of reasons for wanting healthier employees. It is 
therefore important to target the reasons and motivations if senior management are to 
engage successfully in the implementation of Workplace health promotion programmes, 
and for the programmes to be effective and yield results. 
 
Key elements of successful programmes 
The development and implementation of Workplace health promotion 
programmes should consider the following elements: clear goals and objectives, links 
with programmes to business objectives, strong management support and effective 
communication, and supportive environments. 
 
The essential role of a multi-stakeholder approach 
Different stakeholders that can play a role in Workplace health promotion 
include: international organizations; ministries of health, labour and safety; local and 
municipal governments; nongovernmental organizations; civil society; employers; 
employees; trades unions; company health insurance funds; the agriculture industry; food 
producers, catering and food distributors; and the sports industry. 
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This study reinforces the need for low-cost workplace intervention programs.  
Recommendations were made to the management that included implementation of strict 
no smoking policy inside the campus, smoking cessation clinic, health education 
programme to increase awareness about healthy lifestyle, modification of the canteen 
meal menu and to motivate sedentary employees to participate in sports and other 
physical fitness programmes.  
In addition, periodic follow-up of the employees with hypertension, diabetes and 
hypercholesterolemia in the in-house clinic was recommended. All the employees should 
undergo an annual check up, for early detection of any abnormalities. The management 
of the factory was also considering a proposal to start a gymnasium and recreational 
center for the benefit of the employees. 
Comprehensive and integrated action is the means to prevent and control 
chronic diseases. There is no single dedicated programme for Non Communicable 
Diseases. Separate programmes exist such as National Cancer Control Programme, 
National Diabetes Control Programme, National Programme for Control of Blindness. 
These can be Integrated and brought together under one programme, modelled like The 
National Vector Borne Diseases Control Programme (NVBDCP).  
At the center, a Directorate of National Programme for Prevention and 
Control of Non Communicable Diseases, the national level Technical Nodal office 
equipped with Technical Experts in various fields (Public Health, CVDs, Diabetes, 
Cancer, Respiratory conditions, Blindness, etc.) responsible for framing technical 
guidelines and policies to guide the states for implementation of Programme strategies, 
budgeting and planning, monitoring and periodical evaluation. 
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Regional Offices providing technical advice as well as assistance to the state and 
responsible for conducting risk factor surveys, cross checking of blood biochemical 
estimation, capacity building of the states. 
State Level is responsible for implementation of Programme with District non-
communicable disease units under them. 
At the Primary Health Centres early detection and treatment of uncomplicated cases can 
be done. Complicated cases can be referred to Community Health Centres and other 
secondary and tertiary level Health institutions. 
Strengthen research and Information Education and Communication activities. 
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LIMITATIONS 
 
1. The results of the study cannot be generalized to the general urban population as 
the study was done in an industrial population that had higher socio-economic 
status and unique work profile.  
2. In addition, study population essentially consisted of males. 
3. A detailed history of diet and stress was not elicited. 
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ANNEXURE -2 
GLUCOSE ESTIMATION BY GLUCOSE OXIDASE-PEROXIDASE METHOD 
Principle 
Glucose is oxidized by Glucose Oxidase (GOD) into Gluconic Acid and Hydrogen 
Peroxide.  Hydrogen Peroxide in presence of Peroxidase (POD) oxidizes the chromogen 
4-Aminoantipyrine (4 AAP) / phenolic compound to a red coloured compound. The 
intensity of the red coloured compound is proportional to the glucose concentration and is 
measured at 505 nm (490-530 nm). The final compound is stable for 2 hours. 
 
Specimen collection 
Plasma is preferred for glucose determination, but serum separated immediately after 
clotting can also be used. The addition of Sodium Fluoride is recommended to inhibit 
glycolysis. If however this anticoagulant is not used, plasma separation should be carried 
out within 30 minutes of blood sample collection. As far as possible, samples should be 
used on the same day. However, if fluoride with any other anticoagulant is used, then the 
samples are stable for 24hours at room temperature and for 1 week at 2- 8 degree Celsius.  
Reagent (Buffer/Enzymes/Chromogen) 
Phosphate buffer 
4-Aminoantipyrine (4AAP) 
p-Hydroxy Benzoic acid 
Glucose Oxidase 
Peroxidase 
1. Glucose + O2 + H2O Gluconate + H2O2 
Glucose Oxidase 
2. H2O2  + Phenol + 4 AAP Coloured Complex + H2O 
Peroxidase  
Standard 
Glucose 
 
Reaction Parameters 
Type of Reaction   : End Point 
Wavelength   : 505 nm (490-530 nm) 
Incubation   : 15 min, at 37° C 
Standard Concentration : 100 mg/dl 
Sample Volume  : 10 microlitres(0.01ml) 
Reagent Volume  : 1.0 ml 
Zero Setting with  : Reagent Blank 
Light Path   : 1.0 cm 
 
Procedure 
Pipette into test tubes Blank Standard Test 
Reagent (ml) 1.0 1.0 1.0 
Standard (ml) - 0.01 - 
Sample (ml) - - 0.01 
 
Mix well and incubate for 15 minutes, 37° C. Read absorbance of standard and test at 505 
nm (490-530 nm or with green filter) against reagent blank. 
Test Results 
Glucose Concentration (mg/dl) =     Absorbance of Test     × 100 
          Absorbance of Standard 
Linearity 
This method is linear up to 500mg/dl.  
References  
• TINDER P, Annual Clinical Biochemistry 6, 24-25 (1969) 
• TIETZ N.W. Fundamentals of Clinical Chemistry, 2nd edition W.B. Saunders Co. 
(1982) 
 
CHOLESTEROL ESTIMATION BY CHOD-PAP METHOD 
Principle 
The estimation of cholesterol involves the following enzymatic reactions 
 
The intensity of the coloured complex produced is directly proportional to the 
concentration of Cholesterol content which is measured at 505 nm or with green filter. 
Presentation 
1. Cholesterol (Enzymes Chromogen Buffer) 
2. Cholesterol (Buffer Solution) 
3. Cholesterol Standard 200mg/dl 
Specimen Collection 
Fasting fresh, clear unhemolysed serum is the specimen of choice. Plasma prepared with 
anticoagulants such as heparin may be used. 
Reaction Parameters 
Type of Reaction   : End Point 
Sample Volume  : 10 microlitres(0.01ml) 
Reagent Volume  : 1.0 ml 
Wavelength   : 505 nm (490-530 nm) 
Incubation   : 10 min, at 37° C 
Light Path   : 1.0 cm 
Zero Setting with  : Reagent Blank 
 
1. Cholesterol esters Cholesterol + Fatty acids 
Cholesterol esterase 
2. Cholesterol + H2O Cholestenone + H2O2 
Cholesterol Oxidase 
3. H2O2  + Phenol + 4 AAP Quinoneimine 
Peroxidase  
Procedure for colorimeter 
Pipette into test tubes Blank Standard Test 
Reagent (ml) 2.5 2.5 2.5 
Standard (ml) - 0.02 - 
Sample (ml) - - 0.02 
 
Mix well and incubate for 10 minutes, 37° C. Read absorbance of standard and test at 505 
nm (490-530 nm or with green filter) against reagent blank within 30 minutes. 
Test Results 
Cholesterol Concentration (mg/dl) =     Absorbance of Test     × 200 
                Absorbance of Standard 
Linearity 
This method is linear up to 700mg/dl.  
 
References 
• ROESCHCLAUP et al methods of enzymatic Analysis 2nd Edition, H.O. 
Bergmeyer, Academic press New York (1074) 1890 
• FLEGG H.M. Annals of Clinical Biochemistry. 10-79 (1973) 
 
 
1 NAME  
2 AGE
3 SEX 
4 EDUCATION
Professional, P.G
B.A.,B.Sc., Degree 
  Intermediate, High School Diploma
 High School 
 Middle school
 Primary school
 Illiterate
5 OCCUPATION
Professional
 Semi-Professional
Clerk/Shopkeeper 
 Skilled Worker
Semi-Skilled Worker
Unskilled
Unemployed
6 FAMILY INCOME PER MONTH 
7 SOCIOECONOMIC STATUS
8 MARITAL STATUS
Married
Unmarried
Single
     ANNEXURE-1                                                                                                 
PART 1-DEMOGRAPHIC CHARACTERISTICS
A CROSS-SECTIONAL STUDY OF SELECTED  MODIFIABLE  
CARDIOVASCULAR RISK FACTORS AMONG SALES EXECUTIVES 
IN AN URBAN ORGANIZED SECTOR INDUSTRIAL POPULATION IN 
CHENNAI
QUESTIONNAIRE
1 H/O SMOKING
a. Do you currently smoke any cigarettes?^ YES NO Ex-Smoker
b. If Smoker or Ex-Smoker,On an average how
many cigarettes do/did you smoke per day? < 10 >10 cigarettes
c. If Smoker or Ex-Smoker, how long have you
or had you been smoking? years
d. If Ex-Smoker when did you stop smoking? years
e. Do you consume any other tobacco products? YES NO
f. If yes, what do you consume?
2 H/O ALCOHOL CONSUMPTION
a. Do you currently consume alcohol?* YES NO Past Consumer
b. If Consumer or Ex-Consumer, how frequently 
do/did you have at least one alcoholic drink? Regularly ** Occassionally***
c. If Consumer or Ex-Consumer, how long have 
you or had you been drinking? years
d. What type of drink do/did you consume? Beer Wine Whiskey/Rum/Brandy
e. How many drinks do/did you consume per upto 2 3 to 4 5 or more drinks
day?
f. If Ex-Consumer when did you stop drinking? years
5 H/O EXERCISE
a. Do you exercise apart from your daily YES NO
activities?
b. If yes, what type of exercise do you do? walking
jogging
swimming
gymnasium
others
c. How many days in a week do you exercise? 1to2 3to4 5to7 days
d. How long do you exercise per day? < 30 min 30min or more
PART 2 - BEHAVIOURAL CHARACTERISTICS
6 DIET Vegetarian Non-Vegetarian
7 H/O HYPERTENSION
a. Have you been previously diagnosed to have
high Blood Pressure? YES NO
b. If yes, are you on medication? YES NO
c. Do you take your medication regularly? YES NO
8 H/O DIABETES
a. Have you been previously diagnosed to have 
Diabetes? YES NO
b. If yes, are you on medication? YES NO
c. Do you take your medication regularly? YES NO
1 ANTHROPOMETRIC MEASUREMENTS
a. HEIGHT cms
b. WEIGHT kgs
c. BMI kg/m2
2 BLOOD PRESSURE mmHg
3 BIOCHEMICAL MEASUREMENTS
a. FASTING BLOOD SUGAR mg/dl
b. SERUM CHOLESTEROL mg/dl
^Smoked at least one cigarette during the last 30 days
*Consumed at least one alcoholic beverage in the past 30 days
**Alcohol intake for more than three times (average) a week.
***Alcohol intake for more than three times a month, but less than three times a week.
THANK YOU
PART 3 - CLINICAL AND BIOCHEMICAL MEASUREMENTS
